The stock has a 36-month beta value of 0.95. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HIMS is 139.59M, and at present, short sellers hold a 12.51% of that float. On April 30, 2024, the average trading volume of HIMS was 5.08M shares.
HIMS) stock’s latest price update
The stock of Hims & Hers Health Inc (NYSE: HIMS) has increased by 0.40 when compared to last closing price of 12.50. Despite this, the company has experienced a 5.64% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-26 that Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $12.50, signifying a +1.87% move from its prior day’s close.
HIMS’s Market Performance
Hims & Hers Health Inc (HIMS) has seen a 5.64% rise in stock performance for the week, with a -18.88% decline in the past month and a 39.14% surge in the past quarter. The volatility ratio for the week is 3.87%, and the volatility levels for the past 30 days are at 4.90% for HIMS. The simple moving average for the last 20 days is -7.64% for HIMS stock, with a simple moving average of 36.94% for the last 200 days.
Analysts’ Opinion of HIMS
Many brokerage firms have already submitted their reports for HIMS stocks, with Jefferies repeating the rating for HIMS by listing it as a “Hold.” The predicted price for HIMS in the upcoming period, according to Jefferies is $15 based on the research report published on April 16, 2024 of the current year 2024.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see HIMS reach a price target of $20. The rating they have provided for HIMS stocks is “Buy” according to the report published on April 10th, 2024.
Imperial Capital gave a rating of “Outperform” to HIMS, setting the target price at $16 in the report published on February 28th of the current year.
HIMS Trading at -7.99% from the 50-Day Moving Average
After a stumble in the market that brought HIMS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.86% of loss for the given period.
Volatility was left at 4.90%, however, over the last 30 days, the volatility rate increased by 3.87%, as shares sank -19.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +24.88% upper at present.
During the last 5 trading sessions, HIMS rose by +5.64%, which changed the moving average for the period of 200-days by +37.76% in comparison to the 20-day moving average, which settled at $13.43. In addition, Hims & Hers Health Inc saw 41.01% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HIMS starting from Boughton Soleil, who sale 2,503 shares at the price of $13.95 back on Apr 15 ’24. After this action, Boughton Soleil now owns 164,363 shares of Hims & Hers Health Inc, valued at $34,917 using the latest closing price.
Baird Melissa, the Chief Operating Officer of Hims & Hers Health Inc, sale 11,751 shares at $14.74 during a trade that took place back on Apr 08 ’24, which means that Baird Melissa is holding 538,932 shares at $173,254 based on the most recent closing price.
Stock Fundamentals for HIMS
Current profitability levels for the company are sitting at:
- -0.04 for the present operating margin
- 0.82 for the gross margin
The net margin for Hims & Hers Health Inc stands at -0.03. The total capital return value is set at -0.11. Equity return is now at value -7.18, with -5.83 for asset returns.
Based on Hims & Hers Health Inc (HIMS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at 7.58. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 23.88.
Currently, EBITDA for the company is -23.95 million with net debt to EBITDA at 3.07. When we switch over and look at the enterprise to sales, we see a ratio of 2.86. The receivables turnover for the company is 152.85for trailing twelve months and the total asset turnover is 1.98. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.00.
Conclusion
To sum up, Hims & Hers Health Inc (HIMS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
